Activity ID
9036Expires
January 7, 2025Format Type
InternetCME Credit
0.5Fee
$0CME Provider: Massachusetts Medical Society
Description of CME Course
The US EPA estimates that 21,000 radon-related deaths occur annually in the United States. In Massachusetts, radon, a colorless, odorless, tasteless and radioactive gas, is the second leading cause of lung cancer. It is important to understand that health risks can be reduced with testing and radon mitigation. This online CME course focuses on how healthcare providers can play an integral role in providing education and directing their patients to available resources.
This webinar was supported by the Centers for Disease Control and Prevention (CDC) Cooperative Agreement 1 NU58DP006271-01-00. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the CDC.
ABMS Member Board Approvals by Type
ABMS Lifelong Learning CME Activity
Allergy and Immunology
Anesthesiology
Colon and Rectal Surgery
Family Medicine
Medical Genetics and Genomics
Nuclear Medicine
Physical Medicine and Rehabilitation
Plastic Surgery
Preventive Medicine
Psychiatry and Neurology
Radiology
Thoracic Surgery
Urology
Commercial Support?
NoNOTE: If a Member Board has not deemed this activity for MOC approval as an accredited CME activity, this activity may count toward an ABMS Member Board’s general CME requirement. Please refer directly to your Member Board’s MOC Part II Lifelong Learning and Self-Assessment Program Requirements.
Educational Objectives
Describe the link between radon exposure and lung cancer risk
Educate patients on radon risks and mitigation
Explain elevated risk of lung cancer due to smoking status combined with radon exposure
Direct patients to available resources
Keywords
Lung Cancer
Competencies
Medical Knowledge, Practice-based Learning & Improvement
CME Credit Type
AMA PRA Category 1 Credit
Practice Setting
Outpatient, Rural, Urban
